<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32542940/gli-stati-uniti-accelerano-sulla-ricerca-clinica-tra-competizione-globale-e-nuove-sfide-regolatorie</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Gli Stati Uniti accelerano sulla ricerca clinica: tra competizione globale e nuove sfide regolatorie</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542940-ricercabiomedica2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542941/accord-healthcare-rafforza-il-canale-retail-accordo-con-sunrise-healthcare-per-ampliare-l-accesso-alle-cure</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Accord Healthcare rafforza il canale retail: accordo con Sunrise Healthcare per ampliare l’accesso alle cure</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542941-man-woman-pharmacists-discussing-new-medicines.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542942/farmindustria-l-europa-rischia-di-perdere-la-sfida-globale-del-farmaco-</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmindustria: &#34;L&#39;Europa rischia di perdere la sfida globale del farmaco&#34;</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542942-industriafarmaceutica2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542943/ricerca-clinica-farmindustria-l-italia-perde-oltre-10-mila-pazienti-rispetto-alla-spagna-</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Ricerca clinica, Farmindustria: &#34;L&#39;Italia perde oltre 10 mila pazienti rispetto alla Spagna&#34;</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542943-arruolamentopazienti.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542944/tumori-cutanei-e-raggi-uv-una-campagna-contro-i-falsi-miti-dell-esposizione-al-sole</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumori cutanei e raggi UV: una campagna contro i falsi miti dell’esposizione al sole</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542944-campagnalazonapericolosafondazioneumbertoveronesi.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542945/glaucoma-pseudoesfoliativo-la-forma-piu-aggressiva-che-minaccia-la-vista-diagnosi-precoce-e-chirurgia-restano-decisive</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Glaucoma pseudoesfoliativo, la forma più aggressiva che minaccia la vista: diagnosi precoce e chirurgia restano decisive</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542945-woman-working-technology-close-up.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542946/atogepant-ottiene-il-via-libera-europeo-anche-per-il-trattamento-acuto-dell-emicrania</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Atogepant ottiene il via libera europeo anche per il trattamento acuto dell’emicrania</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542946-blonde-woman-having-headache.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542947/farmaco-gemmato-dalla-spesa-ai-principi-attivi-una-strategia-che-guarda-all-autonomia-del-sistema</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaco, Gemmato: dalla spesa ai principi attivi, una strategia che guarda all&#39;autonomia del sistema</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542947-spesafarmaceutica2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542938/malattie-rare-milano-ospita-il-simposio-internazionale-chops-ricerca-clinica-e-famiglie-a-confronto</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Malattie rare, Milano ospita il Simposio internazionale CHOPS: ricerca, clinica e famiglie a confronto</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542938-1.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542948/tumore-del-rene-la-cura-diventa-sempre-piu-personalizzata-meno-invasivita-e-piu-attenzione-alla-qualita-di-vita</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumore del rene, la cura diventa sempre più personalizzata: meno invasività e più attenzione alla qualità di vita</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542948-salt-shape-kidney-dark-floor.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542950/antitrombosi-2-0-dalla-genetica-ai-nuovi-farmaci-la-prevenzione-cardiovascolare-punta-sulla-personalizzazione</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Antitrombosi 2.0: dalla genetica ai nuovi farmaci, la prevenzione cardiovascolare punta sulla personalizzazione</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542950-human-brain-with-highlighted-stroke-area-medical-illustration.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542951/farmaci-innovativi-e-sostenibilita-schillaci-propone-un-patto-tra-stato-e-industria</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaci innovativi e sostenibilità, Schillaci propone un patto tra Stato e industria</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542951-schillaci.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542952/case-di-comunita-i-sindacati-si-dividono-fimmg-verso-l-accordo-smi-respinge-snami-prende-tempo</loc>
  <lastmod>2026-06-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, i sindacati si dividono: Fimmg verso l&#39;accordo, Smi respinge, Snami prende tempo</news:title>
   <news:publication_date>2026-06-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542952-trattativa.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542958/case-di-comunita-il-fronte-del-no-smi-e-snami-contestano-l-accordo</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, il fronte del no: SMI e SNAMI contestano l&#39;accordo</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542958-disaccordo.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542960/vitiligine-la-campagna-che-smonta-i-falsi-miti</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Vitiligine, la campagna che smonta i falsi miti</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542960-anteprimearticolidottnet-2026-06-24t115621344.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542961/dolore-cronico-cosa-significa-vivere-ogni-giorno-con-un-nemico-invisibile-</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Dolore cronico, cosa significa vivere ogni giorno con un “nemico invisibile”</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542961-anteprimearticolidottnet-2026-06-24t121817390.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542962/leucemia-mieloide-acuta-via-libera-europeo-alla-combinazione-orale-decitabina-cedazuridina-con-venetoclax</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Leucemia mieloide acuta: via libera europeo alla combinazione orale decitabina/cedazuridina con venetoclax</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542962-red-blood-cells-model-with-aids-awareness-ribbon-blue-background.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542963/microbisturi-in-ortopedia-pediatrica-oltre-mille-interventi-in-sette-anni-all-ospedale-pediatrico-bambino-gesu</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Microbisturi in ortopedia pediatrica: oltre mille interventi in sette anni all&#39;Ospedale Pediatrico Bambino Gesù</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542963-anteprimearticolidottnet-2026-06-24t124148719.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542964/tumore-della-mammella-triplo-negativo-metastatico-l-europa-apre-all-uso-di-sacituzumab-govitecan-in-prima-linea</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumore della mammella triplo negativo metastatico: l’Europa apre all’uso di sacituzumab govitecan in prima linea</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542964-woman-recovering-after-breast-cancer.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542965/plasma-al-via-il-progetto-petra-unicamillus-guida-la-formazione-per-un-utilizzo-piu-appropriato-e-sicuro</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Plasma, al via il progetto PETRA: UniCamillus guida la formazione per un utilizzo più appropriato e sicuro</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542965-plasma.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542967/gettonisti-oltre-un-miliardo-in-due-anni-il-fenomeno-diventa-strutturale-e-pesa-sui-conti-della-sanita-pubblica</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Gettonisti, oltre un miliardo in due anni: il fenomeno diventa strutturale e pesa sui conti della sanità pubblica</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542967-giuliano3.JPG</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542968/case-di-comunita-la-prudenza-per-ora-dopo-la-firma</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, la prudenza (per ora) dopo la firma</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542968-medicinadelterritorio.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542969/clima-il-riscaldamento-globale-accelera-nell-ultimo-decennio-raddoppiato-il-ritmo-dell-aumento-delle-temperature</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Clima, il riscaldamento globale accelera: nell’ultimo decennio raddoppiato il ritmo dell’aumento delle temperature</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542969-trees-grown-dry-cracked-dry-soil-dry-season-global-warming.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542970/lupus-e-nefrite-lupica-una-survey-nazionale-per-comprendere-il-peso-della-malattia</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Lupus e nefrite lupica, una survey nazionale per comprendere il peso della malattia</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542970-anteprimearticolidottnet-2026-06-24t141800914.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542971/influenza-il-ministero-punta-su-over-60-e-bambini-per-ridurre-i-casi-gravi</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Influenza, il Ministero punta su over 60 e bambini per ridurre i casi gravi</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542971-vaccinoantinfluenzale.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542972/case-di-comunita-schillaci-guarda-gia-oltre-i-mmg-servono-anche-specialisti-</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, Schillaci guarda già oltre i MMG: &#34;Servono anche specialisti&#34;</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542972-medicinaterritoriale7.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542949/prontuario-farmaceutico-confronto-aperto-tra-farmindustria-e-aifa-sul-futuro-dell-innovazione</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Prontuario farmaceutico, confronto aperto tra Farmindustria e AIFA sul futuro dell&#39;innovazione</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542949-farmaciinnovativi2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542974/dipendenze-l-iss-unifica-i-numeri-verdi-e-apre-alla-sfera-digitale</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Dipendenze, l&#39;Iss unifica i numeri verdi e apre alla sfera digitale</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542974-dipendenzadigitale.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542955/case-di-comunita-firmato-l-accordo-schillaci-evita-il-decreto-ma-i-sindacati-restano-divisi</loc>
  <lastmod>2026-06-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, firmato l&#39;accordo. Schillaci evita il decreto ma i sindacati restano divisi</news:title>
   <news:publication_date>2026-06-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542955-accordo.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542956/endometriosi-dieta-antinfiammatoria-e-terapia-cognitivo-comportamentale-nel-mirino-dello-studio-pearl</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Endometriosi: dieta antinfiammatoria e terapia cognitivo-comportamentale nel mirino dello studio PEARL</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542956-4274784.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542959/celiachia-pediatrica-un-intervento-digitale-per-genitori-migliora-la-qualita-di-vita-nei-bambini</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Celiachia pediatrica: un intervento digitale per genitori migliora la qualità di vita nei bambini</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542959-portrait-kids-cocoa-competition-chocolate-heaven-showdown21.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542966/carcinoma-pancreatico-metastatico-quadrupla-combinazione-con-immunoterapia-e-antiangiogenico-migliora-gli-outcome-di-prima-linea</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Carcinoma pancreatico metastatico: quadrupla combinazione con immunoterapia e antiangiogenico migliora gli outcome di prima linea</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542966-pancreasimg.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542976/schillaci-la-sanita-integrativa-e-una-risorsa-ma-servono-nuove-regole-</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Schillaci: &#34;La sanità integrativa è una risorsa, ma servono nuove regole&#34;</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542976-clinica.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542957/il-paradosso-dell-eta-i-tumori-precoci-aumentano-mentre-accelera-l-invecchiamento-biologico-delle-nuove-generazioni</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Il paradosso dell’età: i tumori precoci aumentano mentre accelera l’invecchiamento biologico delle nuove generazioni</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542957-cancroprecoceimg.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542977/tumori-e-immagine-di-se-l-armocromia-entra-nei-percorsi-di-supporto-psicologico-per-le-pazienti-oncologiche</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumori e immagine di sé: l’armocromia entra nei percorsi di supporto psicologico per le pazienti oncologiche</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542977-armocromia.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542979/case-di-comunita-smi-firma-l-accordo-del-veneto-qui-la-partecipazione-e-volontaria-</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, SMI firma l&#39;accordo del Veneto: &#34;Qui la partecipazione è volontaria&#34;</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542979-medicinaterritoriale5.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542980/dermatite-atopica-e-prurigo-nodularis-disponibile-in-italia-nemolizumab-primo-biologico-mirato-contro-l-il-31</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Dermatite atopica e prurigo nodularis: disponibile in Italia nemolizumab, primo biologico mirato contro l’IL-31</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542980-dermatite.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32542981/case-di-comunita-il-confronto-si-sposta-nelle-regioni-fimmg-piemonte-firmare-significa-governare-il-cambiamento-</loc>
  <lastmod>2026-06-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Case di Comunità, il confronto si sposta nelle Regioni. FIMMG Piemonte: &#34;Firmare significa governare il cambiamento&#34;</news:title>
   <news:publication_date>2026-06-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32542981-mmg3.jpg</image:loc>
  </image:image>
 </url>
</urlset>